Affiliation:
1. Terasaki Foundation Laboratory, Los Angeles, CA, USA
Abstract
Summary
Intravenous immunoglobulin (IVIg) reacted with a wide array of human leucocyte antigen (HLA) alleles, in contrast to normal sera, due possibly to the purification of IgG from the pooled plasma. The reactivity of IgG purified from normal sera was compared with that of native sera to determine whether any serum factors mask the HLA reactivity of anti-HLA IgG and whether IgG purified from sera can recognize the HLA types of the corresponding donors. The purified IgG, unlike native sera, mirrored IVIg reactivity to a wide array of HLA-I/-II alleles, indicating that anti-HLA IgG may be masked in normal sera – either by peptides derived from soluble HLA or by those from antibodies. A < 3 kDa peptide from the complementarity-determining region (CDR) of the Fab region of IgG (but not the HLA peptides) masked HLA recognition by the purified IgG. Most importantly, some of the anti-HLA IgG purified from normal sera – and serum IgG from a few donors – indeed recognized the HLA types of the corresponding donors, confirming the presence of auto-HLA antibodies. Comparison of HLA types with the profile of HLA antibodies showed auto-HLA IgG to the donors' HLA antigens in this order of frequency: DPA (80%), DQA (71%), DRB345 (67%), DQB (57%), Cw (50%), DBP (43%), DRB1 (21%), A (14%) and B (7%). The auto-HLA antibodies, when unmasked in vivo, may perform immunoregulatory functions similar to those of therapeutic preparations of IVIg.
Funder
Terasaki Foundation Laboratory
Terasaki Family Foundation
Publisher
Oxford University Press (OUP)
Subject
Immunology,Immunology and Allergy
Reference38 articles.
1. Use of high-dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars-Sinai experience;Jordan;Clin Transplant,2003
2. Post-transplant therapy with high-dose intravenous gammaglobulin: applications to treatment of antibody-mediated rejection;Jordan;Pediatr Transplant,2005
3. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development;Rebellato;Clin Transplant,2006
4. IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients;Shoenfeld;Autoimmunity,2005
5. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus;Toubi;Hum Immunol,2005
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献